News News April 24, 2025 Ajinomoto Co., Inc. to Sell* its Entire Equity Stake in Ajinomoto Althea, a US-based Aseptic Fill/Finish CDMO (*Completed on May 1, 2025) Read more March 20, 2025 Ajinomoto Bio-Pharma Services Awarded CDMO Leadership Awards Read more November 29, 2024 Notice of Phone Outage Due to Power Interruption Read more October 7, 2024 Notice of Discontinuation of certain Products and Services Read more September 5, 2024 Leading Global CDMO Ajinomoto Bio-Pharma Services Joins CMAC as New Translation to Industry Collaborator Read more July 4, 2024 Regarding the problem with the inquiry form; resolved on July 4th. Read more June 12, 2024 Ajinomoto Bio-Pharma Services Announces the Approval of the 32nd Drug Product at their San Diego Sterile Fill Finish Site Read more March 12, 2024 Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence Read more December 27, 2023 Notice Regarding Joint Research Agreement with RIBOMIC Inc. Read more July 21, 2023 Notice Regarding the Display of Consumption Tax Under Japan’s Invoice System GeneDesign, Inc. – Osaka SiteRead more May 18, 2023 Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility Read more April 19, 2023 Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line Read more Loading…Load More Althea Technologies Announces Expanded Roles for Key Executives Previous Page 1 … 6 7 8